Valvular & structural heart disease

Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis

JACC Cardiovasc IntervPublished Registry-based observational cohort study

Main finding · Major adverse eventsResult — go to the resultHazard ratio 0.75 95% CI 0.49–1.16

Authors' conclusion

Current-generation BEVs and SEVs proved similar technical success and midterm clinical efficacy in Sievers type 1 BAV stenosis. Compared to SEVs, BEVs were associated with less permanent pacemaker implantation and moderate or greater paravalvular regurgitation but with more severe patient-prosthesis mismatch.

Study context

Population
Patients with Sievers type 1 bicuspid aortic valve stenosis undergoing TAVR (AD-HOC registry)
Participants
955 patients301 matched pairs
Exposure
BEV vs SEV for TAVR in Sievers type 1 bicuspid aortic valve (BAV) stenosis
  • BEVn = 301
  • SEVn = 301reference
Outcome
Midterm major adverse events:
  • All-cause death
  • Neurologic events
  • Hospitalization for HF
Follow-up
Median 1.3 years
Methodological detailspropensity-score matched (1:1), multicentre (24 international centres)
  • Propensity-score matched (1:1)
  • Multicentre (24 international centres)

Main finding

Major adverse events

Hazard ratio

0.75

95% CI 0.49–1.16

P = 0.200

BEVvs SEV
HR 0.75 (95% CI 0.49–1.16); P = 0.200

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)P value
New permanent pacemaker implantation · 30 daysLower risk with BEV · matched cohort0.42 (0.24–0.72)P = 0.002
Moderate or greater paravalvular regurgitation · 30 daysLower risk with BEV · matched cohort0.16 (0.05–0.48)P = 0.001
Severe patient-prosthesis mismatch · 30 daysHigher risk with BEV · matched cohort3.03 (1.02–8.95)P = 0.045

Technical success

Technical success similar with BEV and SEV (OR 1.38; 95% CI 0.63-3.04)
P = 0.421

Safety

OutcomeOR (95% CI)P value
New permanent pacemaker implantation · 30 days0.42 (0.24–0.72)P = 0.002
Moderate or greater paravalvular regurgitation · 30 days0.16 (0.05–0.48)P = 0.001
Severe patient-prosthesis mismatch · 30 days3.03 (1.02–8.95)P = 0.045

Original publication

Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis. JACC Cardiovasc Interv. Published 3 September 2024. doi:10.1016/j.jcin.2024.07.031

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.